Blog

Blog 2019-03-13T22:32:06+00:00

Health Decisions Supports International Women’s Day 2019

Equal access to health care is an important part of building a gender-balanced world

March 8, 2019

Today, we honor all women around the world as we celebrate International Women’s Day. This year’s theme, #BalanceforBetter, reminds us of the value of a gender-balanced world. At Health Decisions, we’re challenging the status quo in women’s health and working to better the balance for the women of today and tomorrow. We believe a healthy woman can help heal the world. 

Read Health Decisions’ Wish for Every […]

March 8th, 2019|Categories: Uncategorized|

Considerations for Measuring Pain in Clinical Trials

March 7, 2019

From March 7-10 in Atlanta, GA, advocates, researchers and other representatives from the healthcare industry will meet to discuss the latest in women’s sexual health at the Joint International Society for the Study of Women’s Sexual Health (ISSWSH) and International Society for Sexual Medicine (ISSM) Meeting. This year, several presentations will focus on the significant impact pain has on women’s sexual function.

According to the American College of Obstetricians and Gynecologists, almost three […]

March 7th, 2019|Categories: Uncategorized|

International HPV Awareness Day: Driving Progress to Improve Patient Care

Increased understanding of the human papillomavirus can lead to better health outcomes and medical advancement

March 4, 2019

By Andrea S. Lukes, MD, MHSc, FACOG, Chief Medical Officer, Health Decisions and Elizabeth Messersmith, PhD, Chief Development Officer, Novan

March 4, 2019 is the second annual International HPV Awareness Day. This event, initiated by the International Papilloma Society to improve worldwide understanding of the human papillomavirus […]

The Importance of Advocating for Female Participation in Clinical Trials

With treatment responses differing among men and women, it is critical to consider sex differences in clinical studies

February 19, 2019 

By Kristen Snipes, Director, Clinical Operations, Health Decisions 

Is being female a pre-existing condition? In the world of clinical research that was once the prevailing notion. In the past, researchers excluded women from trials because they believed their fluctuating hormones might cause them to […]

February 19th, 2019|Categories: Uncategorized|

2018: A Banner Year for Women’s Health

February 11, 2019

By Dr. Andrea Lukes, MD, MHSc, FACOG, Chief Medical Officer, Health Decisions

2018 was a positive year for women’s health. We saw the release of groundbreaking treatments targeting female populations. Further, there were increased research efforts to support new drugs and diagnostics focused on health issues that predominantly impact women. These advances promise to improve the quality of life for patients globally and signal an increased focus […]

February 11th, 2019|Categories: Uncategorized|

Driving Innovation in Contraceptive Care by Putting the User First

A Q&A with Dr. Régine Sitruk-Ware 
December 17, 2018

Clinical research in contraceptive care has led to several new treatment options in recent years, but with many needs still unaddressed, researchers continue to seek alternative solutions. Dr. Régine Sitruk-Ware of the Population Council’s Center for Biomedical Research, recently named one of the 50 most influential people in health care in 2018 by TIME for her innovative work in female and male contraception, shared insights on how contraceptive care is evolving.

Image result for [...]
</p>
</div></div><div class=

December 17th, 2018|Categories: womens-health-blog|

NAMS 2018: We Can’t Ignore Health Conditions Affecting Half the World’s Population for Half of Their Adult Lives

The North American Menopause Society (NAMS) will hold its 2018 Annual Meeting October 3-6 in San Diego, California. The medical community recognizes the NAMS Annual Meeting as a significant event, and yet it is easy to underestimate the meeting’s full importance.

Think about it. Menopause profoundly affects the health and quality of life of about half of the world’s population for about half of their adult lives. Average female life expectancy in the United States and […]

October 2nd, 2018|Categories: Women's Health|

Celebrating World Contraception Day 2018: Continuing the Quest for the Perfect Contraceptive

World Contraception Day is an annual campaign on September 26, supported by 17 nongovernmental organizations (NGOs), “around a vision where every pregnancy is wanted.” In the words of the World Health Organization, World Contraception Day’s mission is “to improve awareness of all contraceptive methods available and enable young people to make informed choices on their sexual and reproductive health.”

Health Decisions considers World Contraception Day an occasion to celebrate the availability of a wide range of contraceptive options while also recognizing that there is […]

September 25th, 2018|Categories: Contraception, Contraceptive Development, Women's Health|

Sexual Health Month: Highlighting Unmet Medical Needs

Sexual Health Awareness MonthThe American Sexual Health Association is observing September as Sexual Health Month, in keeping with the World Association for Sexual Health designation of World Sexual Health Day. Sexually transmitted infections (STIs) are by far the most widespread sexual health conditions affecting both women and men. The Centers for Disease Control estimates that there are approximately 20 million new cases of STIs in the United States annually. STIs can pose serious health issues, especially for women, […]

A New Oral Option for Management of Endometriosis-Associated Pain

FDA approval of gonadotropin-releasing hormone (GnRH) antagonist elagolix as an oral agent for management of moderate-to-severe pain associated with endometriosis provides an important treatment option for a condition that compromises quality of life for approximately 10% of women of reproductive age. Types of pain associated with endometriosis include painful periods, painful ovulation, pain during or after sexual intercourse and chronic pelvic pain.

Clinical studies that provided a basis for FDA approval demonstrated that three out of four women given 200 mg of elagolix twice a […]

August 14th, 2018|Categories: Endometriosis, Women's Health|
SUBMIT RFP